Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹-1,831 Cr₹-90 Cr₹994 Cr₹970 Cr₹776 Cr

What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?

The latest Profit After Tax ratio of GLENMARK PHARMACEUTICALS is ₹-1,831 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹-1,831 Cr
Mar2024₹-90 Cr
Mar2023₹994 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr

How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2025 ₹-1,831 Cr
Negative
Mar2024 ₹-90 Cr
Negative
Mar2023 ₹994 Cr
2.43
Mar2022 ₹970 Cr
25.02
Mar2021 ₹776 Cr -

Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,903.6 Cr -2.8% 3.3% 49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.8%

3.3%

49.6%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses